Boswellia serrata (Indian Frankincense)

Boswellia serrata is an Ayurvedic herb containing boswellic acids that inhibit 5-lipoxygenase enzyme to reduce inflammatory pathways. The resin extract has been traditionally used for joint health and inflammatory conditions.

Origin & History

Boswellia serrata, known as Indian frankincense, is a tree native to India belonging to the Burseraceae family. The oleogum resin (olibanum) is harvested by making incisions in the bark, yielding a resin containing acid resin (6%), gum (30-36%), and essential oils that can be extracted via steam distillation.

Historical & Cultural Context

Boswellia serrata resin has been used historically in traditional medicine with general oral use of extracts from sap and bark noted for therapeutic purposes. Specific traditional systems, indications, or duration of use are not detailed in the available research.

Health Benefits

• Anti-inflammatory effects through 5-lipoxygenase inhibition by boswellic acids (mechanism established, clinical evidence not detailed)
• Potential therapeutic applications suggested by traditional oral use of extracts (traditional use only, no clinical trials provided)
• Topical formulations exist at 1.2 g/100mL in gels (unapproved products, no clinical efficacy data)
• Contains AKBA (acetyl-11-keto-β-boswellic acid), considered the most potent boswellic acid (mechanism identified, human studies not provided)
• Historical medicinal use of resin preparations (traditional evidence only, specific indications not detailed)

How It Works

Boswellic acids, particularly AKBA (3-O-acetyl-11-keto-β-boswellic acid), selectively inhibit 5-lipoxygenase enzyme, blocking leukotriene synthesis. This interruption of the arachidonic acid cascade reduces pro-inflammatory mediators like LTB4 and 5-HETE. The compounds also modulate nuclear factor-kappa B (NF-κB) signaling pathways.

Scientific Research

The research dossier indicates that search results lack specific details on human clinical trials, RCTs, or meta-analyses for Boswellia serrata, including no PubMed PMIDs, study designs, or outcome data. While general mentions exist of oral therapeutic use, no trial data is provided in the available research.

Clinical Summary

Current clinical evidence for Boswellia serrata remains limited despite established anti-inflammatory mechanisms. While 5-lipoxygenase inhibition by boswellic acids has been demonstrated in laboratory studies, comprehensive human trials with standardized dosing protocols are lacking. Traditional use data supports oral administration of standardized extracts, but quantified clinical outcomes and optimal dosing ranges require further research. Topical formulations exist but clinical efficacy data is not well-documented.

Nutritional Profile

Boswellia serrata resin and extracts are not consumed as a conventional food source, so macronutrient profiling is not the primary framework; however, key compositional data is established. The resin comprises approximately 5–10% essential oils (monoterpenes and diterpenes including α-thujene, α-pinene, and limonene), 60–70% resin acids (triterpenoids), and 20–30% polysaccharides (arabinose, galactose-based gums). The primary bioactive compounds are pentacyclic triterpenic boswellic acids, constituting roughly 25–40% of the dry resin extract: β-boswellic acid (~15–20% of total boswellic acid fraction), acetyl-β-boswellic acid, 11-keto-β-boswellic acid (KBA), and acetyl-11-keto-β-boswellic acid (AKBA, approximately 1–5% in raw resin, enriched to 10–30% in standardized extracts such as Shallaki or 5-Loxin). AKBA is considered the most potent 5-lipoxygenase inhibitor with an IC50 in the low micromolar range. Standardized commercial extracts (e.g., 65% total boswellic acids by HPLC) are the most studied forms. Bioavailability of boswellic acids is notably limited by poor aqueous solubility; oral bioavailability is enhanced when taken with a high-fat meal (lipid co-administration increases Cmax by approximately 2–3 fold). Phospholipid complexes (e.g., Phytosome formulations) further improve absorption. Mineral and vitamin content in resin extracts is negligible and not nutritionally significant. Protein content is minimal (<1%). Dietary fiber equivalents from polysaccharide gums are present but not relevant at supplemental doses (typical clinical doses: 300–500 mg standardized extract, 2–3 times daily).

Preparation & Dosage

No clinically studied dosage ranges for extracts, powder, or standardized forms are detailed in the available research. Topical formulations include 1.2 g/100mL in gels or 0.01 g/100mL in lotions, but these are unapproved products without clinical dosing context. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Turmeric, Ginger, White Willow Bark, Quercetin, Bromelain

Safety & Interactions

Boswellia serrata is generally well-tolerated with mild gastrointestinal effects reported in some users. The herb may interact with anti-inflammatory medications due to its 5-lipoxygenase inhibition mechanism. Safety during pregnancy and breastfeeding has not been established through clinical studies. Individuals with autoimmune conditions should consult healthcare providers before use due to immune system modulation effects.